Using Oral Medications, Infusions and Injections for Differential Diagnosis of Orofacial Pain

References

• Truelove EL, Dworkin SF, et al, Facial and head pain caused by myofascial and temporomandibular disorders. In: Loeser JD, ed. Bonica’s management of pain. Philadelphia, Lippincott Williams and Wilkins, pp 896-901, 2001.
   Google Scholar
• http://www.ninds.nih.gov/disorders/chronic_pain/detail_chronic_pain.htm#23853084. Accessed May 24, 2006.
   Google Scholar
• http://consensus.nih.gov/1996/1996TemporomandibularDisorders018html.htm. Accessed May 24, 2006.
   Google Scholar
• Prado WA, Machado Filho EB, Antinociceptive potency of aminoglycoside antibiotics and magnesium chloride: A comparative study on models of phasic and incisional pain in rats. Braz J Med Biol Res Mar, 35(3):395-403, 2002.
   PubMedGoogle Scholar
• Mao J, Glutamate transporter: An unexpected target for some antibiotics. Mol Pain 1(1):5, Feb. 9, 2005.
   PubMedGoogle Scholar
• Pud D, Yarnitsky D, et al, Can personality traits and gender predict the response to morphine? An experimental cold pain study. Eur J Pain 10(2):103-12, 2006.
   PubMedGoogle Scholar
• Liccardi G, Senna G, et al, Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol 14(2):104-7, 2004.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Silberstein SD, Headache management for the pain specialist. Reg Anesth Pain Med 29(5):462-75, 2004.
   PubMedGoogle Scholar
• Diener HC, Limmroth V, Medication-overuse headache: a worldwide problem. Lancet Neurol 3(8):475-83, 2004.
   PubMed Web of Science ®Google Scholar
• Gerber PE, Lynd LD, Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 32(6):692-8, 1998.
   PubMed Web of Science ®Google Scholar
• Pogrel MA, Thamby S, Permanent nerve involvement resulting from inferior alveolar nerve blocks. J Am Dent Assoc 131(7):901-7, 2000.
   PubMed Web of Science ®Google Scholar
• Baluga JC, Casamayou R, et al, Allergy to local anaesthetics in dentistry. Myth or reality? Allergol Immunopathol (Madr) 30(1):14-9, January-February 2002.
   PubMedGoogle Scholar
• Simons DG, Travell JG, Simons LS, Apropos of all muscles. In: Travell and Simons’ myofascial pain and dysfunction: The trigger point manual. Vol., 1, Upper half of body. Baltimore, Williams and Wilkins, pp 94-177, 1999.
   Google Scholar
• Criscuolo CM, Interventional approaches to the management of myofascial pain syndrome. Curr Pain Headache Rep 5(5):407-11, 2001.
   PubMedGoogle Scholar
• Travell J, Rinzler SH, The myofascial genesis of pain. Postgrad Med 11(5):425-34, 1952.
   PubMedGoogle Scholar
• Garvey TA, Marks MR, Wiesel SW, A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine 14(9):962-4, 1989.
   PubMed Web of Science ®Google Scholar
• Cummings TM, White AR, Needling therapies in the management of myofascial trigger point pain: A systematic review. Arch Phys Med Rehabil 82(7):986-92, 2001.
   PubMed Web of Science ®Google Scholar
• Mense S, Simons DG, Russell IJ, Muscle pain: Understanding its nature, diagnosis and treatment. Philadelphia, Lippincott Williams and Wilkins, 2001.
   Google Scholar
• Alvarez DJ, Rockwell PG, Trigger points: Diagnosis and management. Am Fam Physician 65(4):653-60, 2002.
   PubMed Web of Science ®Google Scholar
• Grubb BD, Peripheral and central mechanisms of pain. Br J Anaesth 81(1):8-11, 1998.
   PubMedGoogle Scholar
• Bridges D, Thompson SW, Rice AS, Mechanisms of neuropathic pain. Br J Anaesth 87(1):12-26, 2001.
   PubMed Web of Science ®Google Scholar
• Scholz J, Woolf CJ, Can we conquer pain? Nat Neurosci 5 Suppl:1062-7, 2002.
   PubMedGoogle Scholar
• Ji RR, Kohno T, et al, Central sensitization and LTP: Do pain and memory share similar mechanisms? Trends Neurosci 26(12):696-705, 2003.
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci 74(21):2605-10, 2004.
   PubMed Web of Science ®Google Scholar
• Purves D, Augustine GJ, et al, Neuroscience. Massachusetts, Sinauer Associates, Inc., pp 209-27, 2004.
   Google Scholar
• Padilla M, Clark GT, Merrill RL, Topical medications for orofacial neuropathic pain: A review. J Am Dent Assoc 131(2):184-95, 2000.
   PubMedGoogle Scholar
• Merrill RL, Intraoral neuropathy. Curr Pain Headache Rep 8(5):341-6, 2004.
   PubMedGoogle Scholar
• Merrill RL, Orofacial pain mechanisms and their clinical application. Dent Clin North Am 41(2):167-88, 1997.
   PubMedGoogle Scholar
• Svensson P, Petersen JK, Anesthetic effect of EMLA occluded with Orahesive oral bandages on oral mucosa. A placebo-controlled study. Anesth Prog 39(3):79-82, 1992.
   PubMedGoogle Scholar
• Svensson P, Petersen JK, Svensson H, Efficacy of a topical anesthetic on pain and unpleasantness during scaling of gingival pockets. Anesth Prog 41(2):35-9, 1994.
   PubMedGoogle Scholar
• Gupta AK, Sibbald RG, Eutectic lidocaine/prilocaine 5 percent cream and patch may provide satisfactory analgesia for excisional biopsy or curettage with electrosurgery of cutaneous lesions. A randomized, controlled, parallel group study. J Am Acad Dermatol 35(3 Pt 1):419-23, 1996.
   PubMedGoogle Scholar
• Griffin RS, Woolf CJ, Pharmacology of analgesia. In: Golan DE, Tashjian AH et al, eds. Principles of pharmacology — The pathophysi-ologic basis of drug therapy. Lippinncott Williams and Wilkins, pp 229-43, 2005.
   Google Scholar
• Arabshahi B, Dewitt EM, et al, Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum 52(11):3563-9, November 2005.
   PubMedGoogle Scholar
• Moore RA, Tramer MR, et al, Quantitative systematic review of topically applied nonsteroidal anti-inflammatory drugs. BMJ 316(7128):333-8, 1998.
   PubMed Web of Science ®Google Scholar
• Sawynok J, Topical and peripherally acting analgesics. Pharmacol Rev 55(1):1-20, 2003.
   PubMed Web of Science ®Google Scholar
• McCleane G, Topical analgesic drugs. In, Smith HS, Drugs for pain. Philadelphia, Hanley and Belfus Inc., pp 393-400, 2003.
   Google Scholar
• Dowling TC, Arjomand M, et al, Relative bioavailability of ketoprofen 20 percent in a poloxamer-lecithin organogel. Am J Health Syst Pharm 61(23):2541-4, 2004.
   PubMed Web of Science ®Google Scholar
• Mazieres B, Rouanet S, et al, Topical ketoprofen patch in the treatment of tendinitis: A randomized, double-blind, placebo-controlled study. J Rheumatol 32(8):1563-70, 2005.
   PubMedGoogle Scholar
• Johansson A, Bennett GJ, Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth 22(1):59-65, 1997.
   PubMedGoogle Scholar
• Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL, Migraine: Current concepts and emerging therapies. Vascul Pharmacol 43(3):176-87, 2005.
   PubMedGoogle Scholar
• Pettengill CA, Reisner-Keller L, The use of tricyclic antidepressants for the control of chronic orofacial pain. Cranio 15(1):53-6, 1997.
   PubMedGoogle Scholar
• Saarto T, Wiffen PJ, Antidepressants for neuropathic pain. Cochrane Database Syst Rev 20(3): CD005454, 2005.
   Google Scholar
• Chopra P, Smith HS, Bajwa, Z, Clinical Pharmacotherapeutics of Headache. In: Drugs for pain. Ed: Smith HS, Philadelphia, Hanley and Belfus Inc., 2003.
   Google Scholar
• Waldman HJ, Centrally acting skeletal muscle relaxants and associated drugs. J Pain Symptom Manage 9(7):434-41, 1994.
   PubMedGoogle Scholar
• Han SC, Harrison P, Myofascial pain syndrome and trigger-point management. Reg Anesth 22(1):89-101, 1997.
   PubMedGoogle Scholar
• Alvarez DJ, Rockwell PG. Trigger points: Diagnosis and management. Am Fam Physician 65(4):653-60, 2002.
   PubMed Web of Science ®Google Scholar
• Tremont-Lukats IW, Challapalli V, et al. Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review and meta-analysis. Anesth Analg 101(6):1738-49, 2005.
   PubMed Web of Science ®Google Scholar
• Galer BS, Harle J, Rowbotham MC, Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study. J Pain Symptom Manage 12(3):161-7, 1996.
   PubMedGoogle Scholar
• Trentin L, Visentin M, The predictive lidocaine test in treatment of neuropathic pain. Minerva Anestesiol 66(3):157-61, discussion 162, 2000.
   PubMedGoogle Scholar
• Cohen SP, Chang AS, et al, The intravenous ketamine test: A predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth Analg 99(6):1753-9, 2004.
   PubMedGoogle Scholar
• Lemming D, Sorensen J, et al, The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain. Clin J Pain 21(5):412-21, 2005.
   PubMedGoogle Scholar
• Rothrock J, The perils of misinterpreting a treatment response. Headache 45(5):599-600, 2005.
   PubMedGoogle Scholar
• Rosenberg JH, Silberstein SD, The headache of SAH responds to sumatriptan. Headache 45(5):597-8, 2005.
   PubMedGoogle Scholar
• Reisner-Keller LA, Pharmacotherapeutics in the management of orofacial pain. Dent Clin North Am 41(2):259-78, 1997.
   PubMedGoogle Scholar
• Dodick DW, Indomethacin-responsive headache syndromes. Curr Pain Headache Rep 8(1):19-26, 2004.
   PubMedGoogle Scholar